Review
Adenosine receptor ligands: differences with acute versus chronic treatment

https://doi.org/10.1016/0165-6147(96)10002-XGet rights and content

Abstract

Adenosine receptors have been the target of intense research with respect to potential use of selective ligands in a variety of therapeutic areas. Caffeine and theophylline are adenosine receptor antagonists, and over the past three decades a wide range of selective agonists and antagonists for adenosine receptor subtypes have been developed. A complication to the therapeutic use of adenosine receptor ligands is the observation that the effects of acute administration of a particular ligand can be diametrically opposite to the chronic effects of the same ligand. This ‘effect inversion’ is discussed here by Ken Jacobson and colleagues, and has been observed for effects on cognitive processes, seizures and ischaemic damage.

References (50)

  • B. Johansson et al.

    Neuroscience

    (1994)
  • O. Nikodijević et al.

    Pharmacol. Biochem. Behav.

    (1993)
  • S. Ferré et al.

    Neuroscience

    (1992)
  • B.E. Garrett et al.

    Eur. J. Pharmacol.

    (1994)
  • C.E. Lau et al.

    Pharmacol. Biochem. Behav.

    (1994)
  • M.K. Ahlijanian et al.

    Life Sci.

    (1986)
  • H.J. Normile et al.

    Brain Res. Bull.

    (1991)
  • M.R. Zarrindast et al.

    Eur. J. Pharmacol.

    (1994)
  • D.K.J.E. von Lubitz et al.

    Eur. J. Pharmacol.

    (1993)
  • L. Molinengo et al.

    Life Sci.

    (1994)
  • G. Zhang et al.

    Eur. J. Pharmacol.

    (1994)
  • D.K.J.E. von Lubitz et al.

    Eur. J. Pharmacol.

    (1993)
  • D.K.J.E. von Lubitz

    Eur. J. Pharmacol.

    (1995)
  • J. Linden

    Trends Pharmacol. Sci.

    (1994)
  • V. Georgiev et al.

    Brain Res.

    (1993)
  • D.K.J.E. von Lubitz et al.

    Eur. J. Pharmacol.

    (1994)
  • D.K.J.E. von Lubitz et al.

    Neuroscience

    (1989)
  • D.K.J.F. von Lubitz

    Eur. J. Pharmacol.

    (1994)
  • D.K.J.F. von Lubitz et al.

    Eur. J. Pharmacol.

    (1995)
  • K.A. Rudolphi et al.

    Neurosci. Lett.

    (1989)
  • D.K.J.E. von Lubitz et al.

    Eur. J. Pharmacol.

    (1994)
  • A. Nehlig et al.

    Brain Res. Rev.

    (1992)
  • B.B. Fredholm

    Pharmacol. Toxicol.

    (1995)
  • J.W. Daly
  • B. Johansson

    Naunyn-Schmied. Arch. Pharmacol.

    (1993)
  • Cited by (245)

    • Caffeine – treat or trigger? Disparate behavioral and long-term dopaminergic changes in control and schizophrenia-like Wisket rats

      2021, Physiology and Behavior
      Citation Excerpt :

      In spite of the common consumption of CAFF, the long-term biochemical effects of its administration have not been comprehensively investigated [72]. A few studies reported the effects of adenosinergic drugs on the dopamine D2 receptor system, but the signaling changes after CAFF administration have not been explored [33,34,69,73]. One possible confounding bias might be that the investigation of the brain was performed over a long period.

    • Genetic background of encephalopathy

      2018, Acute Encephalopathy and Encephalitis in Infancy and Its Related Disorders
    • Chronic ethanol exposure increases inhibition of optically targeted phasic dopamine release in the nucleus accumbens core and medial shell ex vivo

      2017, Molecular and Cellular Neuroscience
      Citation Excerpt :

      An alternative compensatory mechanism to receptor upregulation may be changes in receptor coupling and efficacy, which were not tested here. Conversely, increased receptor function may also result from chronic antagonism of receptor activity (Jacobson et al., 1996; MacLennan et al., 1988). Acute ethanol actions on DA signaling in the NAc are biphasic, with increases in DA levels occurring with low-to-moderate doses of ethanol and decreases in DA levels occurring with high doses of ethanol that coincide with sedation (Imperato and Di Chiara, 1986).

    View all citing articles on Scopus
    View full text